Neutralizing antibodies against human T cell leukemia virus type-I (HTLV-1) eradicate HTLV-1 in combination with autologous peripheral blood mononuclear cells via antibody-dependent cellular cytotoxicity while preventing new infection

Neutralizing antibodies against human T cell leukemia virus type-I (HTLV-1) eradicate HTLV-1 in combination with autologous peripheral blood mononuclear cells via antibody-dependent cellular cytotoxicity while preventing new infection

Bibliographic Details
Main Authors: Tanaka, Yuetsu, Takahashi, Yoshiaki, Kodama, Akira, Tanaka, Reiko, Saito, Mineki
Format: Online
Language:English
Published: BioMed Central 2014
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4044937/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4044937/

Similar Items